Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.
Iptacopan hydrochloride by Novartis for Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes